{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:46:55Z","timestamp":1776502015047,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the 90th anniversary of Chulalongkorn University, the Ratchadaphisek Somphot Fund"},{"name":"Second Century Fund (C2F), Chulalongkorn University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11259-026-11177-5","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:52:34Z","timestamp":1774936354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BRAFV595E detection, uroplakin II expression and PAS staining for diagnosing canine urothelial carcinoma"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2388-3769","authenticated-orcid":false,"given":"Monticha","family":"Kitnitchee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirintra","family":"Sirivisoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesada","family":"Siripoonsub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narisara","family":"Chimnakboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panitnan","family":"Punyathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somporn","family":"Techangamsuwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anudep","family":"Rungsipipat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"11177_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.15654\/tpk-180554","volume":"46","author":"H Aupperle-Lellbach","year":"2018","unstructured":"Aupperle-Lellbach H, Grassinger J, Hohloch C, Kehl A, Pantke P (2018) Diagnostic value of the BRAF variant V595E in urine samples, smears and biopsies from canine transitional cell carcinoma. Tierarztl Prax Ausg K Kleintiere Heimtiere 46:289\u2013295. https:\/\/doi.org\/10.15654\/tpk-180554","journal-title":"Tierarztl Prax Ausg K Kleintiere Heimtiere"},{"key":"11177_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/dc.21632","volume":"40","author":"P Ayra","year":"2012","unstructured":"Ayra P, Khalbuss WE, Monaco SE, Pantanowitz L (2012) Melamed-Wolinska bodies. Diagn Cytopathol 40:150\u2013151. https:\/\/doi.org\/10.1002\/dc.21632","journal-title":"Diagn Cytopathol"},{"key":"11177_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1023\/B:BREA.0000018408.77854.d1","volume":"84","author":"JT Buijs","year":"2004","unstructured":"Buijs JT, Cleton AM, Smit VT, L\u00f6wik CW, Pluijm SEP G (2004) Prognostic significance of periodic acid-Schiff-positive patterns in primary breast cancer and its lymph node metastases. Breast Cancer Res Treat 84:117\u2013130. https:\/\/doi.org\/10.1023\/B:BREA.0000018408.77854.d1","journal-title":"Breast Cancer Res Treat"},{"key":"11177_CR4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1111\/jvim.16107","volume":"35","author":"EM Butty","year":"2021","unstructured":"Butty EM, Hahn S, Labato MA (2021) Presumptive malignant transformation of chronic polypoid cystitis into an apical transitional cell carcinoma without BRAF mutation in a young female dog. J Vet Intern Med 35:1551\u20131557. https:\/\/doi.org\/10.1111\/jvim.16107","journal-title":"J Vet Intern Med"},{"key":"11177_CR5","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1158\/1541-7786.MCR-14-0689","volume":"13","author":"B Decker","year":"2015","unstructured":"Decker B, Parker HG, Dhawan D, Kwon EM, Karlins E, Davis BW, Ramos-Vara JA, Bonney PL, McNiel EA, Knapp DW, Ostrander EA (2015) Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer-Evidence for a Relevant Model System and Urine-Based Diagnostic Test. Mol Cancer Res 13:993\u20131002. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0689","journal-title":"Mol Cancer Res"},{"key":"11177_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tvjl.2015.01.017","volume":"205","author":"CM Fulkerson","year":"2015","unstructured":"Fulkerson CM, Knapp DW (2015) Management of transitional cell carcinoma of the urinary bladder in dogs: a review. Vet J 205:217\u2013225. https:\/\/doi.org\/10.1016\/j.tvjl.2015.01.017","journal-title":"Vet J"},{"key":"11177_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.909934","author":"F Gentilini","year":"2022","unstructured":"Gentilini F, Palgrave CJ, Neta M, Tornago R, Furlanello T, McKay JS, Sacchini F, Turba ME (2022) Validation of a Liquid Biopsy Protocol for Canine BRAFV595E Variant Detection in Dog Urine and Its Evaluation as a Diagnostic Test Complementary to Cytology. Front Vet Sci. https:\/\/doi.org\/10.3389\/fvets.2022.909934","journal-title":"Front Vet Sci"},{"key":"11177_CR8","doi-asserted-by":"publisher","first-page":"986269","DOI":"10.3389\/fvets.2022.986269","volume":"9","author":"VM Govoni","year":"2022","unstructured":"Govoni VM, Pigoli C, Brambilla E, Ruiz Sueiro FA, Torres Neto R, Laufer-Amorim R, Gomes Quitzan J, Grieco V, Fonseca-Alves CE (2022) Caveolin-1, GATA-3, and Ki67 expressions and their correlation with pathological findings in canine bladder urothelial carcinoma. Front Vet Sci 9:986269. https:\/\/doi.org\/10.3389\/fvets.2022.986269","journal-title":"Front Vet Sci"},{"key":"11177_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci6010031","author":"JM Grassinger","year":"2019","unstructured":"Grassinger JM, Merz S, Aupperle-Lellbach H, Erhard H, Klopfleisch R (2019) Correlation of BRAF Variant V595E, Breed, Histological Grade and Cyclooxygenase-2 Expression in Canine Transitional Cell Carcinomas. Vet Sci. https:\/\/doi.org\/10.3390\/vetsci6010031","journal-title":"Vet Sci"},{"key":"11177_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/vco.12095","volume":"14","author":"K Hanazono","year":"2016","unstructured":"Hanazono K, Nishimori T, Fukumoto S, Kawamura Y, Endo Y, Kadosawa T, Uchide T (2016) Immunohistochemical expression of p63, Ki67 and \u03b2-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder. Vet Comp Oncol 14:263\u2013269. https:\/\/doi.org\/10.1111\/vco.12095","journal-title":"Vet Comp Oncol"},{"key":"11177_CR11","doi-asserted-by":"publisher","first-page":"943","DOI":"10.5858\/arpa.2013-0221-OA","volume":"138","author":"LL Hoang","year":"2014","unstructured":"Hoang LL, Tacha DE, Qi W, Yu C, Bremer RE, Chu J, Haas TS, Cheng L (2014) A Newly Developed Uroplakin II Antibody With Increased Sensitivity in Urothelial Carcinoma of the Bladder. Arch Pathol Lab Med 138:943\u2013949. https:\/\/doi.org\/10.5858\/arpa.2013-0221-OA","journal-title":"Arch Pathol Lab Med"},{"key":"11177_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10719-014-9564-4","volume":"31","author":"I K\u0105tnik-Prastowska","year":"2014","unstructured":"K\u0105tnik-Prastowska I, Lis J, Matejuk A (2014) Glycosylation of uroplakins. Implications for bladder physiopathology. Glycoconj J 31:623\u2013636. https:\/\/doi.org\/10.1007\/s10719-014-9564-4","journal-title":"Glycoconj J"},{"key":"11177_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/ilar\/ilu018","volume":"55","author":"DW Knapp","year":"2014","unstructured":"Knapp DW, Ramos-Vara JA, Moore GE, Dhawan D, Bonney PL, Young KE (2014) Urinary Bladder Cancer in Dogs, a Naturally Occurring Model for Cancer Biology and Drug Development. ILAR J 55:100\u2013118. https:\/\/doi.org\/10.1093\/ilar\/ilu018","journal-title":"ILAR J"},{"key":"11177_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/pai.0000000000001021","volume":"30","author":"HL Kristoffersen","year":"2022","unstructured":"Kristoffersen HL, R\u00f8ge R, Nielsen S (2022) Comparison of Antibodies to Detect Uroplakin in Urothelial Carcinomas. Appl Immunohistochem M M 30:326\u2013332. https:\/\/doi.org\/10.1097\/pai.0000000000001021","journal-title":"Appl Immunohistochem M M"},{"key":"11177_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.4251\/wjgo.v16.i3.687","volume":"16","author":"J Lin","year":"2024","unstructured":"Lin J, Chen ZF, Guo GD, Chen X (2024) Impact of Alcian blue and periodic acid Schiff expression on the prognosis of gastric signet ring cell carcinoma. World J Gastrointest Oncol 16:687\u2013698. https:\/\/doi.org\/10.4251\/wjgo.v16.i3.687","journal-title":"World J Gastrointest Oncol"},{"key":"11177_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22:276\u2013282. https:\/\/doi.org\/10.11613\/BM.2012.031","journal-title":"Biochem Med (Zagreb)"},{"key":"11177_CR17","volume-title":"Tumors in Domestic Animals","author":"DJ Meuten","year":"2017","unstructured":"Meuten DJ (2017) Tumors in Domestic Animals. Wiley-Blackwell, New Jersey"},{"key":"11177_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144170","author":"H Mochizuki","year":"2015","unstructured":"Mochizuki H, Shapiro SG, Breen M (2015a) Detection of BRAF Mutation in Urine DNA as a Molecular Diagnostic for Canine Urothelial and Prostatic Carcinoma. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0144170","journal-title":"PLoS ONE"},{"key":"11177_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129534","author":"H Mochizuki","year":"2015","unstructured":"Mochizuki H, Kennedy K, Shapiro SG, Breen M (2015b) BRAF Mutations in Canine Cancers. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0129534","journal-title":"PLoS ONE"},{"key":"11177_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1939-1676.1992.tb00330.x","volume":"6","author":"AM Norris","year":"1992","unstructured":"Norris AM, Laing EJ, Valli VE, Withrow SJ, Macy DW, Ogilvie GK, Tomlinson J, McCaw D, Pidgeon G, Jacobs RM (1992) Canine bladder and urethral tumors: a retrospective study of 115 cases (1980\u20131985). J Vet Intern Med 6:145\u2013153. https:\/\/doi.org\/10.1111\/j.1939-1676.1992.tb00330.x","journal-title":"J Vet Intern Med"},{"key":"11177_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/biomethods\/bpac014","author":"U Oba","year":"2022","unstructured":"Oba U, Kohashi K, Sangatsuda Y, Oda Y, Sonoda KH, Ohga S, Yoshimoto K, Arai Y, Yachida S, Shibata T, Ito T, Miura F (2022) An efficient procedure for the recovery of DNA from formalin-fixed paraffin-embedded tissue sections. Biol Methods Protoc. https:\/\/doi.org\/10.1093\/biomethods\/bpac014","journal-title":"Biol Methods Protoc"},{"key":"11177_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jcpa.2006.07.002","volume":"135","author":"DJ Patrick","year":"2006","unstructured":"Patrick DJ, Fitzgerald SD, Sesterhenn IA, Davis CJ, Kiupel M (2006) Classification of canine urinary bladder urothelial tumours based on the World Health Organization\/International Society of Urological Pathology consensus classification. J Comp Pathol 135:190\u2013199. https:\/\/doi.org\/10.1016\/j.jcpa.2006.07.002","journal-title":"J Comp Pathol"},{"key":"11177_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1522009","author":"R Peng","year":"2025","unstructured":"Peng R, Zhang Y, Jia M, Yi X, Yi X, Li S, Pi J, Meng W (2025) Predicting recurrence of non-muscle invasive bladder urothelial carcinoma: predictive value of the optimal cut-off value of Ki67. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2024.1522009","journal-title":"Front Oncol"},{"key":"11177_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00428-022-03346-z","volume":"481","author":"C Pryma","year":"2022","unstructured":"Pryma C, Villamil C, Gibb EA, Oo HZ, Seiler R, Contreras-Sanz A, Douglas J, Black PC, Wang G (2022) Uroplakin II as a single marker for luminal versus basal molecular subtypes in muscle invasive urothelial carcinoma. Virchows Arch 481:397\u2013403. https:\/\/doi.org\/10.1007\/s00428-022-03346-z","journal-title":"Virchows Arch"},{"key":"11177_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1354\/vp.40-1-55","volume":"40","author":"JA Ramos-Vara","year":"2003","unstructured":"Ramos-Vara JA, Miller MA, Boucher M, Roudabush A, Johnson GC (2003) Immunohistochemical Detection of Uroplakin III, Cytokeratin 7, and Cytokeratin 20 in Canine Urothelial Tumors. Vet Pathol 40:55\u201362. https:\/\/doi.org\/10.1354\/vp.40-1-55","journal-title":"Vet Pathol"},{"key":"11177_CR26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/dc.22994","volume":"42","author":"ER Riley","year":"2014","unstructured":"Riley ER, Paquette C, Leiman G (2014) What exactly are the cytoplasmic inclusions in metastatic urothelial carcinoma, and are they of diagnostic value? Diagn Cytopathol 42:816\u2013818. https:\/\/doi.org\/10.1002\/dc.22994","journal-title":"Diagn Cytopathol"},{"key":"11177_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10577-015-9471-y","volume":"23","author":"SG Shapiro","year":"2015","unstructured":"Shapiro SG, Raghunath S, Williams C, Motsinger-Reif AA, Cullen JM, Liu T, Albertson D, Ruvolo M, Bergstrom Lucas A, Jin J, Knapp DW, Schiffman JD, Breen M (2015) Canine urothelial carcinoma: genomically aberrant and comparatively relevant. Chromosome Res 23:311\u2013331. https:\/\/doi.org\/10.1007\/s10577-015-9471-y","journal-title":"Chromosome Res"},{"key":"11177_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1040638717743280","volume":"30","author":"OR Sierra Matiz","year":"2018","unstructured":"Sierra Matiz OR, Santilli J, Anai LA, Da Silva MCL, Sueiro FA, Sequeira JL, Magalh\u00e3es LF, Magalh\u00e3es GM, Tinucci Costa M, Calazans SG (2018) Prognostic significance of Ki67 and its correlation with mitotic index in dogs with diffuse large B-cell lymphoma treated with 19-week CHOP-based protocol. J Vet Diagn Invest 30:263\u2013267. https:\/\/doi.org\/10.1177\/1040638717743280","journal-title":"J Vet Diagn Invest"},{"key":"11177_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/0300985814522819","volume":"52","author":"DG Sledge","year":"2015","unstructured":"Sledge DG, Patrick DJ, Fitzgerald SD, Xie Y, Kiupel M (2015) Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder. Vet Pathol 52:74\u201382. https:\/\/doi.org\/10.1177\/0300985814522819","journal-title":"Vet Pathol"},{"key":"11177_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/blc-170145","volume":"4","author":"BC Sommer","year":"2018","unstructured":"Sommer BC, Dhawan D, Ratliff TL, Knapp DW (2018) Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies. Bladder Cancer 4:149\u2013159. https:\/\/doi.org\/10.3233\/blc-170145","journal-title":"Bladder Cancer"},{"key":"11177_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/BLC-201523","volume":"7","author":"B Sommer","year":"2021","unstructured":"Sommer B, Dhawan D, Ruple A, Ramos-Vara J, Hahn N, Utturkar S, Ostrander E, Parker H, Fulkerson C, Childress M, Fourez L, Enstrom A, Knapp D (2021) Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog Breed. Bladder Cancer 7:1\u201317. https:\/\/doi.org\/10.3233\/BLC-201523","journal-title":"Bladder Cancer"},{"key":"11177_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/ani14040588","volume":"14","author":"DM Vasilatis","year":"2024","unstructured":"Vasilatis DM, Ghosh PM (2024) Clinicopathologic characterization of prostatic cancer in dogs. Anims 14:588. https:\/\/doi.org\/10.3390\/ani14040588","journal-title":"Anims"},{"key":"11177_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12672-025-01813-y","volume":"16","author":"W Wang","year":"2025","unstructured":"Wang W, Zhang B, Wu Z, Hou C, Li M, Zhang T (2025) Pathological features and immunohistochemical characteristics of clear cell (glycogen-rich) urothelial carcinoma: a case report and systematic review of the literature. Discov Oncol 16:132. https:\/\/doi.org\/10.1007\/s12672-025-01813-y","journal-title":"Discov Oncol"},{"key":"11177_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cvsm.2018.11.002","volume":"49","author":"KL Wycislo","year":"2019","unstructured":"Wycislo KL, Piech TL (2019) Urinary Tract Cytology. Vet Clin North Am Small Anim Pract 49:247\u2013260. https:\/\/doi.org\/10.1016\/j.cvsm.2018.11.002","journal-title":"Vet Clin North Am Small Anim Pract"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-026-11177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11259-026-11177-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-026-11177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:10:39Z","timestamp":1776499839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11259-026-11177-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["11177"],"URL":"https:\/\/doi.org\/10.1007\/s11259-026-11177-5","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Consent to Publish declaration: not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}